Greek TV Exposes Drug Counterfeiting
An international ring based in Athens has been manufacturing andexporting counterfeit drugs, Greece's Mega television channel has reported. The drugs are being sold in Europe, mainly in Italy, France, Belgium, the Netherlands and the UK, but many are also finding their way to Asia and Africa, it claims.
One product identified as being copied is Glaxo Wellcome's Zantac (ranitidine); the president of Glaxo Greece has issued a strong condemnation. The Ministry of Health and Welfare has promised to investigate the matter, and the National Drug Association (the EOF) has issued a statement assuring the public that none of the counterfeit drugs are obtainable in Greek pharmacies, and that it has checked and approved all products.
The reports say the authorities are pursuing an Englishman in connection with the scam, and two Greeks are to be tried soon.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze